
The Rx for High-Performance Leadership: Cutting Through the Chaos
Ken Banta, founder and CEO of The Vanguard Network, reveals the mindsets and moves biopharma leaders need to not just endure—but rise above—the current age of industry disruption.
In a turbulent era for the life sciences, leadership demands clarity, resilience, and adaptability. In this candid podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, shares high-level insights on what CEOs can do to thrive amid the disruption—from regulatory agility to cultural resilience. The corporate strategy expert and author of the new book Seeing Around Corners explains why the best leaders are the best learners—and how prioritization, honesty, and boldness will separate those who merely survive from those who shape the industry’s future.
Highlights of the interview include:
- Navigating a “new maze” at the FDA and its personality-driven complexities
- R&D bets shifting toward proven winners, leaving long-shot breakthroughs behind
- Building trust and culture through transparency in uncertain times
- The call for leaders to embrace continuous learning—from AI startups to lab bench innovators
Click below to listen. View/download the transcript
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.




